The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Farrell Christine since 2006.
The trader's CIK number is 1200160.
At the time of the last reporting, Farrell Christine was the VP of Finance of Bioject Medical Technologies Inc. (stock ticker symbol BJCT).
Also see all insider trading activities at Bioject Medical Technologies Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | BJCT | 0 | $0 | 0 | $0 | 25,000 | $0 |
| 2010 | BJCT | 0 | $0 | 0 | $0 | 39,000 | $0 |
| 2009 | BJCT | 0 | $0 | 0 | $0 | 153,834 | $0 |
| 2009 | BJCT | 0 | $0 | 0 | $0 | 24,000 | $0 |
| 2008 | BJCT | 0 | $0 | 0 | $0 | 41,333 | $0 |
| 2007 | BJCT | 0 | $0 | 0 | $0 | 11,000 | $0 |
| 2006 | BJCT | 0 | $0 | 0 | $0 | 5,000 | $4,450 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-12-31 | BJCT | Option Ex | 25,000 | .00 | 0 |
| 2010-12-31 | BJCT | Option Ex | 39,000 | .00 | 0 |
| 2009-12-31 | BJCT | Option Ex | 24,000 | .00 | 0 |
| 2009-12-07 | BJCT | Option Ex | 5,000 | .00 | 0 |
| 2009-03-08 | BJCT | Option Ex | 25,000 | .00 | 0 |
| 2009-01-30 | BJCT | Option Ex | 75,000 | .00 | 0 |
| 2009-01-19 | BJCT | Option Ex | 834 | .00 | 0 |
| 2008-12-31 | BJCT | Option Ex | 24,000 | .00 | 0 |
| 2008-12-31 | BJCT | Option Ex | 24,000 | .00 | 0 |
| 2008-12-08 | BJCT | Option Ex | 5,000 | .00 | 0 |
| 2008-03-08 | BJCT | Option Ex | 25,000 | .00 | 0 |
| 2008-03-10 | BJCT | Option Ex | 500 | .00 | 0 |
| 2008-01-22 | BJCT | Option Ex | 833 | .00 | 0 |
| 2007-12-31 | BJCT | Option Ex | 10,000 | .00 | 0 |
| 2007-12-07 | BJCT | Option Ex | 5,000 | .00 | 0 |
| 2007-03-26 | BJCT | Option Ex | 2,500 | .00 | 0 |
| 2007-03-26 | BJCT | Option Ex | 2,500 | .00 | 0 |
| 2007-03-10 | BJCT | Option Ex | 500 | .00 | 0 |
| 2007-01-28 | BJCT | Option Ex | 500 | .00 | 0 |
| 2006-10-02 | B | Option Ex | 5,000 | .89 | 4,450 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Farrell Christine (VP of Finance of Bioject Medical Technologies Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.